Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
DCC-2721
print preview
bookmark
share with colleague
General Information
Company
Deciphera Pharmaceuticals LLC
Description
Oral small molecule targeting cMET receptor tyrosine kinase
Molecular Target
c-Met receptor tyrosine kinase
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Solid tumors
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy